

Methylphenidate (MPH) is an amphetamine-like stimulant commonly prescribed for attention deficit hyperactivity disorder. Despite its widespread use, the cellular/molecular effects of MPH remain elusive. Here, we report a novel direct role of MPH on the regulation of macromolecular flux through human brain endothelial cells (ECs). MPH significantly increased caveolae-mediated transcytosis of horseradish peroxidase through ECs without affecting paracellular permeability. Using FRET-based live cell imaging, together with pharmacological inhibitors and lentiviral-mediated shRNA knockdown, we demonstrate that MPH promoted ROS generation via activation of Rac1-dependent NADPH oxidase (NOX) and c-Src activation at the plasma membrane. c-Src in turn was shown to mediate the phosphorylation of caveolin-1 (Cav1) on Tyr14 leading to enhanced caveolae formation and transendothelial transport. Accordingly, the inhibition of Cav1 phosphorylation by overexpression of a phosphodefective Cav1Y14F mutant or knocking down Cav1 expression abrogated MPH-induced transcytosis. In addition, both vitamin C and inhibition of NOX blocked MPH-triggered vesicular transport. This study, therefore, identifies Rac1/NOX/c-Src-dependent signaling in MPH-induced increase in transendothelial permeability of brain endothelial cell monolayers via caveolae-mediated transcytosis. © 2016, Springer International Publishing.
| EMTREE drug terms: | ascorbic acidcaveolin 1methylphenidateprotein tyrosine kinaseRac1 proteinreactive oxygen metabolitereduced nicotinamide adenine dinucleotide phosphate oxidasecaveolin 1CSK tyrosine-protein kinasehorseradish peroxidasemethylphenidateoxidizing agentprotein Cdc42protein tyrosine kinaseRac1 proteinreactive oxygen metabolitereduced nicotinamide adenine dinucleotide phosphate oxidaseRhoA guanine nucleotide binding protein |
|---|---|
| EMTREE medical terms: | Articleblood brain barrierbrain capillary endothelial cellcaveolacell membranecell membrane permeabilitycontrolled studyhumanhuman cellprotein phosphorylationsignal transductiontranscytosisbiological modelbraincapillary permeabilitycaveolacytologydrug effectsendothelium cellenzymologymetabolismphosphorylationtranscytosistransport at the cellular leveltransport vesicle |
| MeSH: | Biological TransportBrainCapillary PermeabilityCaveolaeCaveolin 1cdc42 GTP-Binding ProteinEndothelial CellsHorseradish PeroxidaseHumansMethylphenidateModels, BiologicalNADPH OxidaseOxidantsPhosphorylationrac1 GTP-Binding ProteinReactive Oxygen SpeciesrhoA GTP-Binding ProteinSignal Transductionsrc-Family KinasesTranscytosisTransport Vesicles |
ascorbic acid, 134-03-2, 15421-15-5, 50-81-7; methylphenidate, 113-45-1, 298-59-9; protein tyrosine kinase, 80449-02-1; reduced nicotinamide adenine dinucleotide phosphate oxidase, 9032-22-8;
Caveolin 1; cdc42 GTP-Binding Protein; CSK tyrosine-protein kinase; Horseradish Peroxidase; Methylphenidate; NADPH Oxidase; Oxidants; rac1 GTP-Binding Protein; Reactive Oxygen Species; rhoA GTP-Binding Protein; src-Family Kinases
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Programa Operacional Temático Factores de Competitividade | ||
| P01 HL60678 | ||
| Kyoto University | ||
| University of Illinois | ||
| University of California, San Diego | ||
| Fundação para a Ciência e a Tecnologia See opportunities | ||
| Federación Española de Enfermedades Raras | SFRH/BD/85556/2012,SFRH/BPD/91962/2012,SFRH/BD/84408/2012,SFRH/BPD/91833/2012,UID/NEU/04539/2013,PEST-C/SAU/UI3282/2013 | FEDER |
This work was supported by Project PTDC/NEU-OSD/0312/2012 from Foundation for Science and Technology (FCT Portugal) co-financed by COMPETE and FEDER funds, and strategic projects PEST-C/SAU/UI3282/2013 and UID/NEU/04539/2013. Also, Ph.D. fellowships SFRH/BD/85556/2012 and SFRH/BD/84408/2012 and, postdoctoral fellowship SFRH/BPD/91833/2012 and SFRH/BPD/91962/2012 from FCT Portugal co-financed by QREN. TSummavielle was supported by program Investigador FCT, POPH and Fundo Social Europeu, and RDMinshall by NIH P01 HL60678. We thank Dr. Shu Chien (University of California, San Diego) for providing KRas Src YPet and KRas Src (RV) YPet FRET probes. We thank Dr. Michiyuki Matsuda (Kyoto University) for kindly sharing with us the Raichu-RhoA, Raichu-Rac1 and Raichu-cdc42 FRET probes, and Dr. Andrei Karginov (University of Illinois, Chicago) for providing the RapR-Src construct.
Silva, A.P.; Institute of Pharmacology and Experimental Therapeutics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal;
© Copyright 2017 Elsevier B.V., All rights reserved.